These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 26983987)

  • 21. Hypoxia and Predicting Radiation Response.
    Hill RP; Bristow RG; Fyles A; Koritzinsky M; Milosevic M; Wouters BG
    Semin Radiat Oncol; 2015 Oct; 25(4):260-72. PubMed ID: 26384274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia imaging markers and applications for radiation treatment planning.
    Lin A; Hahn SM
    Semin Nucl Med; 2012 Sep; 42(5):343-52. PubMed ID: 22840599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of hypoxia in the biology and treatment of brain tumors.
    Knisely JP; Rockwell S
    Neuroimaging Clin N Am; 2002 Nov; 12(4):525-36. PubMed ID: 12687909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia as a biomarker for radioresistant cancer stem cells.
    Peitzsch C; Perrin R; Hill RP; Dubrovska A; Kurth I
    Int J Radiat Biol; 2014 Aug; 90(8):636-52. PubMed ID: 24844374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor hypoxia and reoxygenation: the yin and yang for radiotherapy.
    Hong BJ; Kim J; Jeong H; Bok S; Kim YE; Ahn GO
    Radiat Oncol J; 2016 Dec; 34(4):239-249. PubMed ID: 28030900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-regulated expression of attenuated diphtheria toxin A fused with hypoxia-inducible factor-1alpha oxygen-dependent degradation domain preferentially induces apoptosis of hypoxic cells in solid tumor.
    Koshikawa N; Takenaga K
    Cancer Res; 2005 Dec; 65(24):11622-30. PubMed ID: 16357173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical studies of hypoxia modification in radiotherapy.
    Kaanders JH; Bussink J; van der Kogel AJ
    Semin Radiat Oncol; 2004 Jul; 14(3):233-40. PubMed ID: 15254866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies to overcome accelerated repopulation and hypoxia--what have we learned from clinical trials?
    Corry J; Rischin D
    Semin Oncol; 2004 Dec; 31(6):802-8. PubMed ID: 15599858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy.
    Toustrup K; Sørensen BS; Alsner J; Overgaard J
    Semin Radiat Oncol; 2012 Apr; 22(2):119-27. PubMed ID: 22385919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays.
    Chapman JD; Engelhardt EL; Stobbe CC; Schneider RF; Hanks GE
    Radiother Oncol; 1998 Mar; 46(3):229-37. PubMed ID: 9572615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing aspects of radiation oncology.
    Fowler JF
    Med Phys; 1981; 8(4):427-34. PubMed ID: 6798395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitization of hypoxic tumour cells--clinical experience.
    Overgaard J
    Int J Radiat Biol; 1989 Nov; 56(5):801-11. PubMed ID: 2573679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the tumor microenvironment influence radiation-induced apoptosis?
    Hunter A; Hendrikse A; Renan M; Abratt R
    Apoptosis; 2006 Oct; 11(10):1727-35. PubMed ID: 16927015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microenvironment and radiation therapy.
    Yoshimura M; Itasaka S; Harada H; Hiraoka M
    Biomed Res Int; 2013; 2013():685308. PubMed ID: 23509762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor hypoxia and anemia: impact on the efficacy of radiation therapy.
    Kumar P
    Semin Hematol; 2000 Oct; 37(4 Suppl 6):4-8. PubMed ID: 11068949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting tumors with hypoxia-activated cytotoxins.
    Ahn GO; Brown M
    Front Biosci; 2007 May; 12():3483-501. PubMed ID: 17485316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
    Wachsberger P; Burd R; Dicker AP
    Clin Cancer Res; 2003 Jun; 9(6):1957-71. PubMed ID: 12796357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of SCCVII tumor cell survival in clamped and non-clamped solid tumors exposed to carbon-ion beams in comparison to X-rays.
    Hirayama R; Uzawa A; Takase N; Matsumoto Y; Noguchi M; Koda K; Ozaki M; Yamashita K; Li H; Kase Y; Matsufuji N; Koike S; Masunaga S; Ando K; Okayasu R; Furusawa Y
    Mutat Res; 2013 Aug; 756(1-2):146-51. PubMed ID: 23735375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic advantage of hypoxic cells in tumors: a theoretical study.
    Brown JM; Koong A
    J Natl Cancer Inst; 1991 Feb; 83(3):178-85. PubMed ID: 1988703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.